Pharmaceuticals

We reiterate our Outperform rating on eye-care and surgical products maker Cooper Companies Inc (COO) following its strong fourth-quarter and fiscal 2010 results and management's upbeat guidance. Revenues and earnings for the quarter and fiscal year beat the Zacks Consensus Estimate, boosted by...

We reiterate our Outperform rating on eye-care and surgical products maker Cooper Companies Inc (COO) following its strong fourth-quarter and fiscal 2010 results and management's upbeat guidance. Revenues and earnings for the quarter and fiscal year beat the Zacks Consensus Estimate, boosted by...

Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that it has entered into an agreement with Takeda Pharmaceutical Company Limited to settle patent litigation related to Teva's generic versions of Takeda's ACTOS® (pioglitazone HCl) and ACTOplus met® (pioglitazone HCl and metformin...

Small biotechnology companies are making moves not seen in months if not years. Stocks like Radient Pharmaceuticals Corporation (AMEX: RPC) has shot higher by a massive 100% in the last couple days. Other stocks like Antigenics, Inc. (NASDAQ: AGEN) and Poniard Pharmaceuticals, Inc. (NASDAQ: PARD)...

Pfizer (NYSE: PFE) is recalling an additional 19,000 bottles Lipitor, citing a consumer complaint about an "uncharacteristic" odor. This has been the fourth recall since August over the smell issue. Shares of PFE are up 12 cents in early Tuesday trading to $17.29, a gain of 0.7%.

Piper Jaffray is out with a research report this morning, where it reiterates its Overweight rating on Salix Pharmaceuticals (NASDAQ: SLXP); it has a $60.00 price target on the stock. The PJ analysts said that Xifaxan prescription trends continue to be strong through early December, pointing to...

Amylin Pharmaceuticals, Inc. (AMLN) recently announced that it has initiated the filing of a rolling Biologics License Application (BLA) for metreleptin. The company is seeking US Food and Drug Administration (FDA) approval for the use of metreleptin in the treatment of diabetes and/or...

Amylin Pharmaceuticals, Inc. (AMLN) recently announced that it has initiated the filing of a rolling Biologics License Application (BLA) for metreleptin. The company is seeking US Food and Drug Administration (FDA) approval for the use of metreleptin in the treatment of diabetes and/or...

King Pharmaceuticals, Inc. (KG) and partner Acura Pharmaceuticals, Inc. (ACUR) recently announced the submission of a new drug application (NDA) for their opioid candidate, Acurox. The companies are seeking US Food and Drug Administration (FDA) approval for the use of Acurox (without niacin) for...

Biogen Idec (BIIB) recently announced that it has acquired a subsidiary of privately held Swiss biotech company Neurimmune. Following this deal, Biogen will acquire worldwide rights to three immunotherapy programs which are currently in the pre-clinical stage. Terms of the Deal Per the terms...

King Pharmaceuticals, Inc. (KG) and partner Acura Pharmaceuticals, Inc. (ACUR) recently announced the submission of a new drug application (NDA) for their opioid candidate, Acurox. The companies are seeking US Food and Drug Administration (FDA) approval for the use of Acurox (without niacin) for...

Biogen Idec (BIIB) recently announced that it has acquired a subsidiary of privately held Swiss biotech company Neurimmune. Following this deal, Biogen will acquire worldwide rights to three immunotherapy programs which are currently in the pre-clinical stage. Terms of the Deal Per the terms...

Safeguard Scientifics, Inc. (NYSE: SFE) today announced that it expects to receive a minimum of $36 million in initial sale proceeds from the successful completion of Eli Lilly and Company's (NYSE: LLY) acquisition of partner company Avid Radiopharmaceuticals, Inc., which took place earlier today,...